SANOFICONRNSESanofi Consumer Healthcare India LimitedCriticalNeutral
Announced Tue, 6 May · 10:19 IST

Citigroup Global Markets India Pvt. Ltd. (Manager to the Offer) has submitted to the Exchange a copy of Disclosure in relation to number of Equity Shares tendered in connection with the Open Offer on May 05,2025

Open Offer TriggeredListed Co AcquisitionStrategic Transactions View source PDFExplain this filing

SANOFICONR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.1%1-day move
₹4948.89
prior close
₹4954.20
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0-0.0+0.0+0.1+0.2-1.1-1.0-0.4+1.4+3.0+1.3+7.2+7.3
Up moveDown movePending
AI summary

Citigroup Global Markets, the manager to the open offer for Sanofi Consumer Healthcare India, has disclosed that 15,29,681 equity shares (25.55% of the offer size) have been tendered by public shareholders as of May 5, 2025. The tendering broke down as 13,03,988 shares on May 3 and 46,758 shares on May 5. The open offer is for up to 59,87,962 shares (26% of voting capital) by Opal Bidco SAS along with Clayton, Dubilier & Rice Fund XII as persons acting in concert. Tendered shares will still be subject to validation, and the final accepted number may differ from the tendered count.

Likely market impact

Public shareholders have tendered nearly the full 26% offer size, indicating strong acceptance of the open offer. Once validated, this acquisition will result in a change in control of Sanofi Consumer Healthcare India, potentially affecting liquidity and shareholder composition post-offer.